There are reports of vision loss following intravitreal injections of autologous "stem cells" for age-related macular degeneration. The treatment appears to be unregulated and unapproved, with some outlets highlighting the need for greater enforcement by regulatory bodies. The use of stem cell interventions for retinal degeneration is an area of ongoing research, with various studies and reviews exploring its potential benefits and risks.